SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Cryo Cell International Inc (CCEL)

NYSE: CCEL · Real-Time Price · USD
4.32+0.41 (+10.49%)
 
Market Cap34.83M-3.6%
Revenue (ttm)n/a-2.7%
Net Incomen/a-1339.8%
EPSn/a-880.7%
Shares Out8.06M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume38,199
Open4.04
Previous Close3.91
Day's Range3.70 - 4.65
52-Week Range2.72 - 4.90
Betan/a
AnalystsHold
Price Target8.50(+96.76%)
Earnings Daten/a
+10.49% (1D)
No price history available.
Insider Score
––Not scored
CCEL Insider Score

Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About CCEL

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Address
700 Brooker Creek Boulevard, Oldsmar, FL, 34677, United States
Market Cap
35 million
Employees
72
Industrial Classification
Medical Care Facilities
1 Day
+10.49%
5 Days
+5.11%
1 Month
+1.41%
6 Months
+15.82%
1 Year
-3.57%

$CCEL stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CCEL holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CCEL's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CCEL Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New CCEL patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CCEL from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CCEL

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$397.69K
VXFVanguard Extended Market ETF$190.32K

Estimated from each fund’s disclosed top holdings × AUM

CCEL Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for CCEL yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from CCEL’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.